The tumor ablation market is expected to grow at a CAGR of 11.13%, reaching a market size of US$2.125 billion in 2030 from US$1.575 billion in 2025. Tumor ablation is an image-guided technology that is used for tre...
The tumor ablation market is expected to grow at a CAGR of 11.13%, reaching a market size of US$2.125 billion in 2030 from US$1.575 billion in 2025.
Tumor ablation is an image-guided technology that is used for treating tumors and cancer of the lungs, kidneys, liver, bone, etc. This technique offers efficiency in the diagnosis and prevention of tumors in their early stages. It is a minimally invasive procedure where thermal energy is used for heating and cooling the tissue to cytotoxic levels. Radiofrequency, microwave, laser, and cryoablation are common tumor ablation technology.
-
Growth Drivers of the Tumor Ablation Market
The rising cases of cancer and the increasing number of cancer patients are one of the major factors driving the global tumor ablation market growth. The lifestyle and modern diet of people have increased the rate of tumors and cancers in people, resulting in the growing demand for treatment and diagnosis methods like tumor ablation in the global market. Also, the technological advancements and up-gradation in research and development techniques employed in ablation devices are stimulating the global tumor ablation market growth. The high research and development investments made by several companies are raising the market share of the global tumor ablation market in the global healthcare and medical sector.
-
Segmentation of the Tumor Ablation Market
The tumor ablation market is driven by continued innovation in technology. There are increasing advancements in radiofrequency (RF) ablation, microwave ablation and other merging technologies that are offering more efficiency in diagnosis and tumor treatments. For example, in July 2024, AngioDynamics partnered with Immunophotonics to explore synergies in the combination of tumor ablation techniques and immunotherapy. The two companies are seeking to study how immunotherapy can amplify the immune response induced by tumor ablation, thus hopefully leading to better patient outcomes and a stronger anti-tumor effect.
The tumor ablation market is segmented, by technology, into radiofrequency (rf) ablation, microwave ablation, cryoablation, and other technologies. Radiofrequency ablation refers to using high-frequency electrical currents to generate heat that destroys abnormal tissues. Microwave ablation uses electromagnetic waves to generate heat which targets the diseased tissue, offering higher temperature production resulting in faster and effective treatment. Cryoablation refers to using extreme cold to destroy abnormal or diseased tissue. During the forecast period, although radiofrequency ablation will continue to dominate the market as it is well-established in clinical practices, microwave ablation will be growing significantly too as it is offering more effective treatment.
The tumor ablation market is segmented by application into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, and Other Applications. Tumor ablation is used to diagnose and treat liver cancer by using RF and microwave technology to destroy the abnormal tissue. This market is growing due to the increasing incidence of liver cancer. In lung cancer, tumor ablation is used with RF and microwave ablation technology to target abnormal tissue. During the forecast period, lung cancer and liver cancer segment will be growing significantly due to more efficiency offered by ablation technology and also the growing prevalence of liver and lung cancer.
Based on geography, the North American region is expected to dominate the global tumor ablation market in the forecasted years. The increasing investments made by government organisations along with advanced healthcare infrastructure and several companies in this region in cancer treatment and diagnosis techniques are one of the factors boosting tumor ablation market growth.
-
Key Players in the Tumor Ablation Market
The report includes the major players operating in the tumor ablation market are Healthtronics, Inc., Medtronic, PLC, Sonacare Medical, Boston Scientific Corporation, Edap TMS S.A., Misonix, Inc., Galil Medical, Inc., Neuwave Medical, Inc., Mermaid Medical A/S, and Angiodynamics, Inc.
View a sample of the report or purchase the complete study at: https://www.knowledge-sourcing.com/report/tumor-ablation-market
The Tumor Ablation Market is analyzed into the following segments:
- By Technology
- Radiofrequency (Rf) Ablation
- Microwave Ablation
- Cryoablation
- Other Technologies
- By Mode of Treatment
- Surgical Ablation
- Laparoscopic Ablation
- Percutaneous Ablation
- By Application
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Bone Metastasis
- Other Applications
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- Germany
- France
- UK
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- Others
- Asia Pacific
- China
- India
- Japan
- South Korea
- Taiwan
- Thailand
- Indonesia
- Others
- North America
- T-Cell Immunotherapy Market Report
- Cancer Cachexia Market Size
- Cancer Gene Therapy Market Report
Have questions?
More Press Releases
Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031
The worldwide market for lifestyle-associated cancer epidemiology is expected to expand rapidly, owing to the rising global awareness of modifiable risk factors such as tobacco use, obesity, poor diet, alcohol consumption, and physical inactivity, which together contribute significantly to cancer incidence. Health organizations, along with research institutions, are investing in enhanced surveillance, behavioral risk monitoring, cancer registries, and prevention strategies to address the growing burden of preventable cancers. In recent years, the World Health Organization and several national bodies have emphasized data-driven epidemiology. These initiatives support targeted interventions, policy measures, and screening programs. Additionally, the widespread adoption of digital epidemiology tools, precision prevention approaches, and AI-powered analytics is fueling the demand for robust epidemiology infrastructure worldwide.
Psycho-Oncology Digital Health Market is anticipated to surpass USD 290.01 million in 2031 at a CAGR of 8.5%
The psycho-oncology digital health market is expanding as healthcare providers increasingly integrate digital mental health solutions into cancer care. Growing demand for AI-driven platforms, digital cognitive behavioral therapy, telehealth, and mobile applications is improving access to psychological support. North America leads the market, while Asia Pacific is expected to witness the fastest growth.
Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031
The worldwide market for Intratumoral Injection Therapy is expected to experience substantial growth in the market due to the increasing demand for localized cancer treatments that are essential in enhancing therapeutic efficacy while also minimizing systemic toxicity. Intramural injection therapy is often involved with direct administration of therapeutic agents into tumors, which enables high local drug concentrations and targets immune activation. Growing interest in gene therapies, cancer immunotherapy, and on-politic viruses, including cytokine-based therapies are also accelerating market expansion.